Galectin Therapeutics (GALT) Preferred Dividend Payments (2010 - 2026)
Galectin Therapeutics (GALT) posted quarterly Preferred Dividend Payments of $21000.0 for Q1 2026, up 180.77% year-over-year from $7479.5 in Q1 2025, and down 66.13% quarter-over-quarter from $62000.0 in Q4 2025.
Powered by 
Analysis
Galectin Therapeutics (GALT) Preferred Dividend Payments (2010 - 2026) Analysis & Trends
Galectin Therapeutics' Preferred Dividend Payments history runs 17 years deep, the most recent figure standing at $21000.0 for Q1 2026.
- In Q1 2026, Preferred Dividend Payments rose 180.77% year-over-year to $21000.0; the TTM figure through Mar 2026 stood at $185000.0 (up 55.46% YoY), while the FY2025 annual figure was $138000.0, down 9.8% from the prior year.
- Preferred Dividend Payments for Q1 2026 stood at $21000.0, down from $62000.0 in the prior quarter.
- The five-year high for Preferred Dividend Payments was $65000.0 in Q4 2022, with the low at -$26000.0 in Q1 2025.
- The 5-year median for Preferred Dividend Payments is $50500.0 (2025), against an average of $33062.5.
- The sharpest annual moves came in 2022 and 2024: Preferred Dividend Payments slumped 900.0% in 2022, then surged 400.0% in 2024.
- Galectin Therapeutics' Preferred Dividend Payments stood at $65000.0 in 2022, then slipped by 3.08% to $63000.0 in 2023, then changed by 0.0% to $63000.0 in 2024, then slipped by 1.59% to $62000.0 in 2025, then sank by 66.13% to $21000.0 in 2026.
- Business Quant data shows GALT's Preferred Dividend Payments at $21000.0 in Q1 2026, $62000.0 in Q4 2025, and $39000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Galectin Therapeutics | 305.33 Mn | 305.33 Mn | - | 62,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | -26,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | 63,000.00 |
| Dec 31, 2022 | 65,000.00 |
| Sep 30, 2022 | -16,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | -16,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 37,000.00 |
| Jun 30, 2021 | 65,000.00 |